Brief Depression Screener Developed Using IRT for Antenatal and Postpartum Women

使用 IRT 为产前和产后妇女开发简短的抑郁症筛查仪

基本信息

批准号：
7482625
负责人：
BENJAMIN B BRODEY
金额：
$ 9.62万
依托单位：
TELESAGE, INC.
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-05-15 至 2008-11-14
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7482625
关键词：
Address Anxiety Area Caring Child Client satisfaction Clinic Clinical Cognitive Confusion Data Data Analyses Depressed mood Development Diagnostic Event Family Goals Gold Grant Health Health Care Visit Hyperactive behavior Information Systems Interview Language Length Life Light Measurement Measures Mental Depression Mental Health Mental Health Services Modeling National Institute of Mental Health Numbers Outcome Patient currently pregnant Patients Perinatal Phase Physicians Postpartum Depression Postpartum Women Pregnancy Private Sector Problem behavior Process Psychopathology Public Health Public Sector Recommendation Recruitment Activity Reporting Research Research Personnel Risk Sampling Scotland Screening procedure Services Site Small Business Funding Mechanisms Small Business Innovation Research Grant Standards of Weights and Measures Structure Surveys Symptoms Technology Testing Time United States Validation Visit Woman base day depressive symptoms experience improved inattention instrument interest maternal depression men programs psychologic response satisfaction sound success time use

项目摘要

DESCRIPTION (provided by applicant): Estimates of antenatal and postpartum depression vary from 7 percent to upwards of 30 percent depending on criteria for depression, the type of assessment used, and the timing of the assessment. Thus, approximately 320,000 to over 1 million women each year experience symptoms of perinatal depression. Estimates of antenatal depression are harder to obtain because of the lack of appropriate diagnostic criteria. Despite this, no screener currently exists that has been developed and tested with both antenatal and postpartum women that uses concise, simple language, and a consistent response option set. The overall aim of this project is to develop a brief screener to assess depressive symptoms among antenatal and postpartum women. The proposed screener will be easier for patients to understand, will take less time, and will be more psychometrically sound than current screeners. In Phase I we will develop approximately 30 items that are specific to depression in antenatal and postpartum women. We will test these items using cognitive interviewing among a sample of 10 antenatal and 10 postpartum women in addition to 32 general depression items we have previously developed. Experts will review the results of the cognitive interviewing to develop the item pool that will be tested in Phase II. The Phase II item pool will consist of at least 20 general depression items, 10 items specific to antenatal women, and 10 items specific to postpartum women. In Phase II, 500 antenatal and 500 postpartum women (70 percent from private sector sites and 30 percent from public sector sites) will complete the EPDS (as a screener into the study), BDI-II, the PROMIS depression items, our items, and the depression module of the SCID. IRT analyses will be conducted on these data to develop a 7-9 item screener. We anticipate that approximately 5-7 of these items will be applicable to both antenatal and postpartum women and approximately 2-3 of these items will be sample specific. The developed screener will then be given to 400 women who will take the survey twice, approximately 4-7 days apart. Conclusions regarding test-retest reliability and patient satisfaction with taking the screener using different modes of technologies will be made from this study. PUBLIC HEALTH RELEVANCE: Depression among pregnant and postpartum women has been associated with adverse health outcomes and psychopathology, both for these women and for their children and families. The proposed project aims to develop a brief, efficient screener for antenatal or postpartum depression, so that women who are depressed can be identified quickly during regular healthcare visits and can begin to receive appropriate services promptly. The proposed screener would improve upon existing measures not only through use of simpler, more concise language, but also through its development process, which entails collecting responses from pregnant and postpartum women directly.

描述（由申请人提供）：产前和产后抑郁症的估计从 7% 到 30% 以上不等，具体取决于抑郁症标准、所用评估类型和评估时间。因此，每年大约有 32 万至超过 100 万女性出现围产期抑郁症症状。由于缺乏适当的诊断标准，产前抑郁症的估计很难获得。尽管如此，目前还没有针对产前和产后妇女开发和测试的筛查程序，该筛查程序使用简洁、简单的语言和一致的反应选项集。该项目的总体目标是开发一个简短的筛查工具来评估产前和产后妇女的抑郁症状。与现有的筛查仪相比，拟议的筛查仪将更容易让患者理解，花费的时间更少，并且在心理测量上更合理。在第一阶段，我们将开发大约 30 种针对产前和产后女性抑郁症的产品。除了我们之前开发的 32 个一般抑郁项目外，我们还将通过认知访谈对 10 名产前妇女和 10 名产后女性样本进行测试。专家将审查认知访谈的结果，以开发将在第二阶段进行测试的项目库。第二阶段项目库将包括至少 20 个一般抑郁症项目、10 个针对产前女性的项目和 10 个针对产后女性的项目。在第二阶段，500 名产前妇女和 500 名产后妇女（70% 来自私营部门站点，30% 来自公共部门站点）将完成 EPDS（作为研究的筛选者）、BDI-II、PROMIS 抑郁症项目、我们的项目、和 SCID 的抑制模块。将对这些数据进行 IRT 分析，以开发 7-9 项筛选器。我们预计其中大约 5-7 个项目将适用于产前和产后妇女，其中大约 2-3 个项目将针对特定样本。然后，开发的筛查仪将提供给 400 名女性，她们将接受两次调查，间隔大约 4-7 天。本研究将得出有关使用不同技术模式进行筛查的重测可靠性和患者满意度的结论。公共卫生相关性：孕妇和产后妇女的抑郁症与这些妇女及其子女和家庭的不良健康结果和精神病理学有关。拟议项目旨在开发一种简短、有效的产前或产后抑郁症筛查方法，以便在定期医疗保健就诊期间能够快速识别抑郁症妇女，并能够立即开始接受适当的服务。拟议的筛查程序将改进现有措施，不仅通过使用更简单、更简洁的语言，而且通过其开发过程，其中需要直接收集孕妇和产后妇女的反应。